Rockefeller Capital Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Rockefeller Capital Management's CDLX Position: Q1 2026 in Review
Rockefeller Capital Management held its Cardlytics (CDLX) position steady in Q1 2026 at 225 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #4387.
Rockefeller Capital Management first reported a position in CDLX in Q3 2018 and has held it in 16 quarters since. The position peaked at $27M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Rockefeller Capital Management held 225 shares of Cardlytics worth $2.36K as of Q1 2026.
- Rockefeller Capital Management left its Cardlytics share count unchanged in Q1 2026.
- Cardlytics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4387 holding.
- Rockefeller Capital Management first reported a position in Cardlytics in Q3 2018 and has held it in 16 quarters since.
- Rockefeller Capital Management's Cardlytics position peaked at $27M in Q4 2020.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.